Author
Listed:
- Xiaoqin Luo
(Department of Nutrition and Food Safety, School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China
Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China)
- Hexiang Yang
(Department of Nutrition and Food Safety, School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China
Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China)
- Zhangya He
(Department of Nutrition and Food Safety, School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China
Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China)
- Shanshan Wang
(Department of Nutrition and Food Safety, School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China
Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China)
- Chao Li
(Department of Epidemiology and Health Statistics, School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China)
- Tao Chen
(Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China
Department of Public Health, Policy & Systems, Institute of Population Health, Whelan Building, Quadrangle, The University of Liverpool, Liverpool L 69 3GB, UK)
Abstract
Objective: Our study aimed to estimate the number of hypertension patients with or without elevated body mass index (BMI), and assess their mortality risk. Methods: We used data from the China Health and Retirement Longitudinal Study (CHARLS) to estimate the population of hypertensive patients with or without elevated BMI. The mortality risk of hypertension with elevated BMI was estimated by using the China Health and Nutrition Survey (CHNS) data. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals (CI). Results: In total, 23.02% of adults, representing 117.74 (95% CI: 108.79, 126.69) million, had both high BMI and hypertension. Among them, 38.53 (95% CI: 35.50, 41.56) million were recommended to initiate antihypertensive medication but did not take it. Moreover, there were 38.40 (95% CI: 35.50, 41.56) million hypertensive patients with elevated BMI who did not achieve the goal of blood pressure control. All-cause mortality and premature death mortality, especially for the elderly, were significantly and positively associated with the severity of the hypertensive condition ( p for trend = 0.001). Conclusion: In China, there were a huge number of patients with hypertension and elevated BMI, and the treatment and control rates for them were low. The more severe the degree of hypertension, the higher risk of all-cause death and premature death in these patients.
Suggested Citation
Xiaoqin Luo & Hexiang Yang & Zhangya He & Shanshan Wang & Chao Li & Tao Chen, 2021.
"Numbers and Mortality Risk of Hypertensive Patients with or without Elevated Body Mass Index in China,"
IJERPH, MDPI, vol. 19(1), pages 1-12, December.
Handle:
RePEc:gam:jijerp:v:19:y:2021:i:1:p:116-:d:709403
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2021:i:1:p:116-:d:709403. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.